144 related articles for article (PubMed ID: 23631379)
21. Preparation of sustained release microparticles with improved initial release property.
Jung GY; Na YE; Park MS; Park CS; Myung PK
Arch Pharm Res; 2009 Mar; 32(3):359-65. PubMed ID: 19387579
[TBL] [Abstract][Full Text] [Related]
22. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
Hsu YY; Hao T; Hedley ML
J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
[TBL] [Abstract][Full Text] [Related]
23. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles.
Gaignaux A; Réeff J; Siepmann F; Siepmann J; De Vriese C; Goole J; Amighi K
Int J Pharm; 2012 Nov; 437(1-2):20-8. PubMed ID: 22903047
[TBL] [Abstract][Full Text] [Related]
24. Sustained release of low molecular weight heparin from PLGA microspheres prepared by a solid-in-oil-in-water emulsion method.
He J; Zhou Z; Fan Y; Zhou X; Du H
J Microencapsul; 2011; 28(8):763-70. PubMed ID: 22034953
[TBL] [Abstract][Full Text] [Related]
25. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release.
Hao S; Wang Y; Wang B; Deng J; Zhu L; Cao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():113-9. PubMed ID: 24863206
[TBL] [Abstract][Full Text] [Related]
26. Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.
Uchida T; Yagi A; Oda Y; Goto S
J Microencapsul; 1996; 13(5):509-18. PubMed ID: 8864988
[TBL] [Abstract][Full Text] [Related]
27. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres.
Pérez C; Griebenow K
Biotechnol Bioeng; 2003 Jun; 82(7):825-32. PubMed ID: 12701149
[TBL] [Abstract][Full Text] [Related]
28. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
[TBL] [Abstract][Full Text] [Related]
29. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
30. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations.
Devrim B; Bozkır A; Canefe K
Drug Dev Ind Pharm; 2011 Nov; 37(11):1376-86. PubMed ID: 21548727
[TBL] [Abstract][Full Text] [Related]
31. Studies on the preparation, characterization and pharmacological evaluation of tolterodine PLGA microspheres.
Sun F; Sui C; Teng L; Liu X; Teng L; Meng Q; Li Y
Int J Pharm; 2010 Sep; 397(1-2):44-9. PubMed ID: 20600717
[TBL] [Abstract][Full Text] [Related]
32. Controlled release of protein drugs from newly developed amphiphilic polymer-based microparticles composed of nanoparticles.
Kakizawa Y; Nishio R; Hirano T; Koshi Y; Nukiwa M; Koiwa M; Michizoe J; Ida N
J Control Release; 2010 Feb; 142(1):8-13. PubMed ID: 19804802
[TBL] [Abstract][Full Text] [Related]
33. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres.
Janoria KG; Mitra AK
Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of D, L-PLA loaded 17-β-Estradiol valerate by emulsion/evaporation methods.
Machado SR; Lunardi LO; Tristão AP; Marchetti JM
J Microencapsul; 2009 May; 26(3):202-13. PubMed ID: 18942000
[TBL] [Abstract][Full Text] [Related]
35. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
[TBL] [Abstract][Full Text] [Related]
36. Effects of formulation parameters on encapsulation efficiency and release behavior of thienorphine loaded PLGA microspheres.
Yang Y; Gao Y; Mei X
Pharm Dev Technol; 2013; 18(5):1169-74. PubMed ID: 21967467
[TBL] [Abstract][Full Text] [Related]
37. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization.
Doan TV; Olivier JC
Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562
[TBL] [Abstract][Full Text] [Related]
38. Improving protein delivery from microparticles using blends of poly(DL lactide co-glycolide) and poly(ethylene oxide)-poly(propylene oxide) copolymers.
Yeh MK; Davis SS; Coombes AG
Pharm Res; 1996 Nov; 13(11):1693-8. PubMed ID: 8956336
[TBL] [Abstract][Full Text] [Related]
39. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
[TBL] [Abstract][Full Text] [Related]
40. Fabrication and drug release study of double-layered microparticles of various sizes.
Lee WL; Seh YC; Widjaja E; Chong HC; Tan NS; Loo SC
J Pharm Sci; 2012 Aug; 101(8):2787-97. PubMed ID: 22573569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]